India's Ebola Probability Falls to 11% After 11,000 Travelers Screened

India's implied probability of reporting an Ebola case in 2026, tracked on prediction markets covering which countries will report a case before January 1, 2027, has fallen from 32% to 11% over three days after the government screened nearly 11,000 international arrivals from affected countries and detected zero cases.

The move lands India at its period low. Kalshi prices the contract at 9%, while Polymarket sits at 13%, a 4-point spread that suggests both platforms agree directionally: traders consider India increasingly unlikely to import a case before the market's January 1, 2027 resolution date.

The question is whether that confidence is earned or premature.

---

India's Ebola Odds Crash to 11% in 2026 Despite DRC Outbreak Crossing 6,000 Cases

The DRC outbreak is not slowing down. Congo authorities confirmed more than 6,000 cases and nearly 3,000 deaths as of late August, and weekly case counts in North Kivu nearly doubled from roughly 100 to over 200 in just two weeks around September 16. Congo has since begun vaccinating health workers in Bunia, the epicenter, but the campaign targets only 20,000 individuals and uses a vaccine with no proven efficacy against the circulating Bundibugyo strain.

Against that backdrop, India's probability should, on paper, be stable or rising. Instead it cratered. No single confirmed catalyst from the past 72 hours explains the full 21-point swing. The most plausible driver is cumulative: months of screening data with zero detections have reached a critical mass of evidence, and traders appear to be adjusting all at once.

---

How India's Ebola Screening Program Processed Nearly 11,000 Travelers With Zero Detections

India's containment strategy is not theoretical. Between May 23 and July 28, 2026, the government screened 10,974 international passengers arriving from Ebola-affected countries, producing zero confirmed cases. Health Minister J.P. Nadda confirmed the results publicly, and the Ministry of Health and Family Welfare issued multiple advisories urging vigilance among recent travelers from affected regions.

This is active surveillance, not passive monitoring. The program specifically targets arrivals from the DRC and neighboring countries, funneling them through health checkpoints that measure symptoms and trace travel histories. The zero-detection rate across nearly 11,000 screenings is the concrete data point traders appear to be pricing. It transforms India's Ebola risk from an abstract epidemiological question into a measurable filtration problem, and the filter is currently catching everything.

The high-level review meeting convened on May 20, shortly after the WHO declared a Public Health Emergency of International Concern, further signals institutional commitment. India's government is treating this as a priority, and the market is pricing that posture accordingly.

---

The Case Against India: Why 11% Is Not Zero and the DRC Outbreak Could Still Change the Math

Eleven percent is not a dismissal of risk. It implies roughly a 1-in-9 chance that India reports a confirmed case before year-end. With more than three months remaining, that probability carries real weight, and several factors could push it higher.

First, screening programs catch symptomatic travelers. They do not catch individuals in Ebola's incubation period, which can last up to 21 days. A pre-symptomatic carrier clearing airport health checks in Delhi or Mumbai would enter one of the world's densest urban environments undetected. India's air connectivity to African hubs, including direct and one-stop routes through Nairobi, Addis Ababa, and Johannesburg, means the volume of potentially exposed travelers extends well beyond the nearly 11,000 already screened.

Second, the DRC outbreak is a large and active viral reservoir. At 6,000-plus confirmed cases, it dwarfs the 2022 DRC outbreak contained at under 200 cases. The 2014 West Africa epidemic demonstrated how rapidly containment assumptions can fail: Liberia, Sierra Leone, and Guinea all reported exponential growth after initial screening and isolation protocols appeared to be working. Screening success at month three does not guarantee screening success at month six.

Third, a single imported case would radically reprice this market. The move from 11% back toward 30% or higher could happen in a single trading session if Indian health authorities confirmed even one suspected case. Traders buying at 11% are betting on sustained perfection across every screening checkpoint for the next 98 days.

The Kalshi-Polymarket spread (9% versus 13%) reflects some of this uncertainty. Polymarket's higher price may incorporate slightly more caution about tail risk, though both platforms agree the probability belongs in low double digits rather than the 30s where it sat less than a week ago.

---

Live Odds: Track India's Ebola Probability Through Year-End

Prediction-market view

Live prices, venue by venue

Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.

India

Consensus YES price across 2 venues

18%average

KalshiBest YES price10¢Polymarket43¢

Central African Republic

Consensus YES price across 1 venues

38%average

KalshiBest YES price40¢

Tanzania

Consensus YES price across 1 venues

16%average

KalshiBest YES price17¢

Zambia

Consensus YES price across 1 venues

11%average

KalshiBest YES price12¢

Current new-user offer · Kalshi

Get a $35 trading bonusCode PRED35

New users only. Eligibility restrictions and terms apply.

View current offer

The market resolves on January 1, 2027. Any laboratory-confirmed Ebola case reported by Indian health authorities or the WHO before that date would trigger a YES resolution for India. The current 11% price means traders assign about a 1-in-9 probability to that outcome.

What to watch: the DRC's weekly case trajectory, any WHO alerts about cross-border transmission to East African countries with strong travel links to India, and whether India's screening program reports its first detection. The Ethiopia contract on the same event dropped from 54% to 36% over the same three-day window, suggesting traders are broadly reducing exposure on non-African countries as vaccination campaigns begin in the DRC. For the full market with all country outcomes and live pricing, see the Ebola case tracker for 2026.

India's 21-point drop reflects a real and measurable containment signal. Nearly 11,000 screenings with zero detections is not noise. But the market is pricing a bet on sustained institutional performance against a growing outbreak, and that bet has 98 days left to play out.